Código QR

Effectiveness and safety assessment of drospirenone/ethinyl estradiol tablet in treatment of PCOS patients: a single center, prospective, observational study

Abstract Background To investigate the effectiveness and safety of 3 mg drospirenone and 20 μg ethinyl estradiol tablet (3 mg DRSP/20 μg EE) in the treatment of polycystic ovary syndrome (PCOS). Methods This single center, prospective observational study was conducted in 140 patients with PCOS. They...

Descrición completa

Gardado en:
Principais autores: Li Li, Ruiqin Zhang, Jing Zeng, Hu Ke, Xiuhong Peng, Liying Huang, Hongmei Zhang, Zhijing Chen, Tian Tian Li, Qiuxiao Tan, Ying Yang, Xiaofang Li, Xin Li
Formato: Artigo
Idioma:Inglês
Publicado: BMC 2020-02-01
Series:BMC Women's Health
Assuntos:
Drospirenone
Ethinyl estradiol
PCOS
COC
Acceso en liña:http://link.springer.com/article/10.1186/s12905-020-00905-x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares